The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon.
The Glaucoma Research Foundation (GRF) awarded the 2010 Shaffer Prize for Innovative Glaucoma Research to Kate Keller, PhD. Dr Keller is Research Assistant Professor, Department of Ophthalmology at Casey Eye Institute in Portland, Oregon.
Kate Keller, PhD, was awarded the Shaffer Prize for her research investigating the role of Glycosaminoglycans (GAGs) in fluid outflow resistance in the trabecular meshwork of the eye. In primary open-angle glaucoma, there is increased resistance to aqueous flow through the trabecular meshwork, which results in increased intraocular pressure (IOP). GAGs are long sugar chains synthesized by the addition of sugar residues by specific enzymes, and are a likely source of outflow resistance. Experimental results from this study could potentially lead to new therapies for lowering eye pressure in patients with primary open-angle glaucoma.
Dr. Keller published her results in the scientific journals Investigative Ophthalmology and Visual Science and Experimental Eye Research. A native of Scotland, Dr. Keller received her PhD from the University of Edinburgh and obtained postdoctoral training as a Fellow in the laboratories of Dr Nick Morris and Dr Lynn Sakai.
AAO 2024: Detail outlined for Artificial Intelligence Innovation Center at Wilmer Eye Institute
October 24th 2024During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.